142 related articles for article (PubMed ID: 10051142)
1. Mibefradil (Ro 40-5967) inhibits several Ca2+ and K+ currents in human fusion-competent myoblasts.
Liu JH; Bijlenga P; Occhiodoro T; Fischer-Lougheed J; Bader CR; Bernheim L
Br J Pharmacol; 1999 Jan; 126(1):245-50. PubMed ID: 10051142
[TBL] [Abstract][Full Text] [Related]
2. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells.
Nilius B; Prenen J; Kamouchi M; Viana F; Voets T; Droogmans G
Br J Pharmacol; 1997 Jun; 121(3):547-55. PubMed ID: 9179399
[TBL] [Abstract][Full Text] [Related]
4. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones.
Viana F; Van den Bosch L; Missiaen L; Vandenberghe W; Droogmans G; Nilius B; Robberecht W
Cell Calcium; 1997 Oct; 22(4):299-311. PubMed ID: 9481480
[TBL] [Abstract][Full Text] [Related]
5. The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels.
Mehrke G; Zong XG; Flockerzi V; Hofmann F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1483-8. PubMed ID: 7996461
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.
Aczél S; Kurka B; Hering S
Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
Triggle DJ
J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells.
Rossier MF; Ertel EA; Vallotton MB; Capponi AM
J Pharmacol Exp Ther; 1998 Dec; 287(3):824-31. PubMed ID: 9864260
[TBL] [Abstract][Full Text] [Related]
9. Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries.
Bian K; Hermsmeyer K
Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):191-6. PubMed ID: 7694155
[TBL] [Abstract][Full Text] [Related]
10. High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.
Eller P; Berjukov S; Wanner S; Huber I; Hering S; Knaus HG; Toth G; Kimball SD; Striessnig J
Br J Pharmacol; 2000 Jun; 130(3):669-77. PubMed ID: 10821797
[TBL] [Abstract][Full Text] [Related]
11. Effect of mibefradil on sodium and calcium currents.
Strege PR; Bernard CE; Ou Y; Gibbons SJ; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G249-53. PubMed ID: 15790762
[TBL] [Abstract][Full Text] [Related]
12. Effects of mibefradil, a blocker of T-type Ca2+ channels, in single myocytes and intact muscle of guinea-pig heart.
Emanuel K; Mackiewicz U; Pytkowski B; Lewartowski B
J Physiol Pharmacol; 1998 Dec; 49(4):577-90. PubMed ID: 10069698
[TBL] [Abstract][Full Text] [Related]
13. Mibefradil, A T-type calcium channel antagonist in Y1 cells.
Esneu M; Gallo-Payet N; Payet MD
Endocr Res; 1998; 24(3-4):449-54. PubMed ID: 9888524
[TBL] [Abstract][Full Text] [Related]
14. HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers.
Chouabe C; Drici MD; Romey G; Barhanin J; Lazdunski M
Mol Pharmacol; 1998 Oct; 54(4):695-703. PubMed ID: 9765513
[TBL] [Abstract][Full Text] [Related]
15. Role of an inward rectifier K+ current and of hyperpolarization in human myoblast fusion.
Liu JH; Bijlenga P; Fischer-Lougheed J; Occhiodoro T; Kaelin A; Bader CR; Bernheim L
J Physiol; 1998 Jul; 510 ( Pt 2)(Pt 2):467-76. PubMed ID: 9705997
[TBL] [Abstract][Full Text] [Related]
16. An ether -à-go-go K+ current, Ih-eag, contributes to the hyperpolarization of human fusion-competent myoblasts.
Bijlenga P; Occhiodoro T; Liu JH; Bader CR; Bernheim L; Fischer-Lougheed J
J Physiol; 1998 Oct; 512 ( Pt 2)(Pt 2):317-23. PubMed ID: 9763622
[TBL] [Abstract][Full Text] [Related]
17. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
Gomora JC; Xu L; Enyeart JA; Enyeart JJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of the T-type Ca2+ current of mouse spermatogenic cells.
Arnoult C; Villaz M; Florman HM
Mol Pharmacol; 1998 Jun; 53(6):1104-11. PubMed ID: 9614215
[TBL] [Abstract][Full Text] [Related]
19. T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytes.
Hoischen S; Brixius K; Schwinger RH
J Cardiovasc Pharmacol; 1998 Aug; 32(2):323-30. PubMed ID: 9700997
[TBL] [Abstract][Full Text] [Related]
20. Involvement of K(Ca) channels and stretch-activated channels in calcium influx, triggering membrane fusion of chick embryonic myoblasts.
Shin KS; Park JY; Ha DB; Chung CH; Kang MS
Dev Biol; 1996 Apr; 175(1):14-23. PubMed ID: 8608860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
